Pospisilik JA - Search Results

1

A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.

Lynn FC, Thompson SA, Pospisilik JA, Ehses JA, Hinke SA, Pamir N, McIntosh CH, Pederson RA. Lynn FC, et al. Among authors: pospisilik ja. FASEB J. 2003 Jan;17(1):91-3. doi: 10.1096/fj.02-0243fje. Epub 2002 Nov 15. FASEB J. 2003. PMID: 12475913

2

Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat.

Piteau S, Olver A, Kim SJ, Winter K, Pospisilik JA, Lynn F, Manhart S, Demuth HU, Speck M, Pederson RA, McIntosh CH. Piteau S, et al. Among authors: pospisilik ja. Biochem Biophys Res Commun. 2007 Nov 3;362(4):1007-12. doi: 10.1016/j.bbrc.2007.08.115. Epub 2007 Aug 29. Biochem Biophys Res Commun. 2007. PMID: 17803965

3

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.

Pamir N, Lynn FC, Buchan AM, Ehses J, Hinke SA, Pospisilik JA, Miyawaki K, Yamada Y, Seino Y, McIntosh CH, Pederson RA. Pamir N, et al. Among authors: pospisilik ja. Am J Physiol Endocrinol Metab. 2003 May;284(5):E931-9. doi: 10.1152/ajpendo.00270.2002. Epub 2003 Jan 21. Am J Physiol Endocrinol Metab. 2003. PMID: 12540373 Free article.

4

Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.

Ehses JA, Casilla VR, Doty T, Pospisilik JA, Winter KD, Demuth HU, Pederson RA, McIntosh CH. Ehses JA, et al. Among authors: pospisilik ja. Endocrinology. 2003 Oct;144(10):4433-45. doi: 10.1210/en.2002-0068. Epub 2003 Jun 19. Endocrinology. 2003. PMID: 12960055

5

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA. Pospisilik JA, et al. Diabetes. 2003 Mar;52(3):741-50. doi: 10.2337/diabetes.52.3.741. Diabetes. 2003. PMID: 12606516

6

Dipeptidyl peptidase IV inhibition in animal models of diabetes.

Pospisilik JA, Ehses JA, Doty T, McIntosh CH, Demuth HU, Pederson RA. Pospisilik JA, et al. Adv Exp Med Biol. 2003;524:281-91. doi: 10.1007/0-306-47920-6_34. Adv Exp Med Biol. 2003. PMID: 12675250 No abstract available.

7

Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?

McIntosh CH, Demuth HU, Pospisilik JA, Pederson R. McIntosh CH, et al. Among authors: pospisilik ja. Regul Pept. 2005 Jun 15;128(2):159-65. doi: 10.1016/j.regpep.2004.06.001. Regul Pept. 2005. PMID: 15780435 Review.

8

Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.

McIntosh CH, Demuth HU, Kim SJ, Pospisilik JA, Pederson RA. McIntosh CH, et al. Among authors: pospisilik ja. Int J Biochem Cell Biol. 2006;38(5-6):860-72. doi: 10.1016/j.biocel.2005.12.013. Epub 2006 Jan 11. Int J Biochem Cell Biol. 2006. PMID: 16442340 Review.

9

Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.

Pospisilik JA, Stafford SG, Demuth HU, McIntosh CH, Pederson RA. Pospisilik JA, et al. Diabetes. 2002 Sep;51(9):2677-83. doi: 10.2337/diabetes.51.9.2677. Diabetes. 2002. PMID: 12196458

10

Metabolism of glucagon by dipeptidyl peptidase IV (CD26).

Pospisilik JA, Hinke SA, Pederson RA, Hoffmann T, Rosche F, Schlenzig D, Glund K, Heiser U, McIntosh CH, Demuth H. Pospisilik JA, et al. Regul Pept. 2001 Jan 12;96(3):133-41. doi: 10.1016/s0167-0115(00)00170-1. Regul Pept. 2001. PMID: 11111019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page